Accelerated Hypofractionated Image-Guided vs Conventional Radiotherapy for Patients With Stage II/III Non-Small Cell Lung Cancer and Poor Performance Status: A Randomized Clinical Trial.
Iyengar P, Zhang-Velten E, Court L, Westover K, Yan Y, Lin MH, Xiong Z, Patel M, Rivera D, Chang J, Saunders M, Shivnani A, Lee A, Hughes R, Gerber D, Dowell J, Gao A, Heinzerling J, Li Y, Ahn C, Choy H, Timmerman R.
JAMA Oncol. 2021 Oct 1;7(10):1497-1505. doi: 10.1001/jamaoncol.2021.3186.
PMID:34383006
The role of biologically effective dose (BED) in clinical oncology.
Jones B, Dale RG, Deehan C, Hopkins KI, Morgan DA.
Stereotactic Radiosurgery for Postoperative Metastatic Surgical Cavities: A Critical Review and International Stereotactic Radiosurgery Society (ISRS) Practice Guidelines.
Redmond KJ, De Salles AAF, Fariselli L, Levivier M, Ma L, Paddick I, Pollock BE, Regis J, Sheehan J, Suh J, Yomo S, Sahgal A.
Large variation in radiation therapy fractionation for multiple myeloma in Australia.
Ong WL, MacManus M, Milne RL, Foroudi F, Millar JL.
Asia Pac J Clin Oncol. 2023 Feb;19(1):149-157. doi: 10.1111/ajco.13783. Epub 2022 May 22.
PMID:35599450
SMILE-stereotactic multiple fraction radiotherapy for non-spine bone metastases: study protocol for a multicenter, open-label phase III randomized controlled trial.
Foerster R, Zwahlen DR, Schroeder C, Windisch P, Halatsch ME, Alfieri A, Meier C, Hemmatazad H, Aebersold DM, Buchali A, Habermehl D, Batifi N.
Trials. 2024 Nov 13;25(1):762. doi: 10.1186/s13063-024-08608-6.
PMID:39538259
Re-irradiation of multiple brain metastases using CyberKnife stereotactic radiotherapy: Case report.
Zhou H, Wu T, Zhu X, Li Y.
Medicine (Baltimore). 2021 Oct 15;100(41):e27543. doi: 10.1097/MD.0000000000027543.